The Council has published a transcript of a conversation from the WDC summit on prevention and brain health. The participants were Professor Kaarin Anstey, University of New South Wales, Professor Miia Kivipelto, Karolinska Intitutet and Sarah Lenz Lock, AARP. The session was moderated by Hilary Evans, CEO Alzheimer's Research UK.
The Council has published a transcript from a dialogue at the World Dementia Council summit between Professor Bart de Strooper director of the Dementia Research Institute, Dr Maria Carrillo, Chief Scientific Officer Alzheimer's Association, Professor Colin Masters, University of Melbourne and Dr Nadeem Sarwar, Global Head for Genomics Strategy, Eisai.
Arthena Caston was diagnosed with MCI in 2016. Prior to her diagnosis, Arthena was working in customer support for a large insurance company when she began noticing lapses in her memory. At home, Arthena found favorite pursuits, including reading, cooking, and routine trips to the craft store were becoming more challenging.
A global dialogue as part of the dementia landscape project series will gather international leaders on 10 November 2021 to discuss the priorities and challenges faced by early career research scientists working in the field of dementia.
A global dialogue as part of the dementia landscape project series will gather international leaders, who have lived experience of dementia, on 1 November 2021 to discuss the important policy priorities from their individual perspectives.
A global dialogue as part of the dementia landscape project series will gather international leaders on 26 October 2021 to discuss social and psychosocial research in dementia.
A global dialogue as part of the dementia landscape project series will gather international leaders on 21 October 2021 to explore future approaches to the development of disease modifying treatments in non-amyloid targets.
The WDC is delighted to announce that four new individuals have been appointed to join the Council.
Professor Paulo Caramelli obtained his MD in 1987 at the University of São Paulo (USP) School of Medicine, in São Paulo, Brazil and completed the residency program in Neurology at the Hospital das Clínicas of the USP School of Medicine in 1991. Research fellow at the University of Montréal, Canada, from 1992 to 1994. In 1997, he completed a PhD in Neurological Sciences at the USP School of Medicine.
Hilary Evans-Newton is Chief Executive of Alzheimer’s Research UK (ARUK), the UK’s leading dementia research charity. ARUK is committed to investigating the causes of dementia and developing ways to prevent, diagnose, treat and, ultimately, cure all forms of the condition. As Chief Executive since 2015, Hilary has led the transformation of the charity to one of the leading medical research charities in the UK. She has overseen a significant growth in income in recent years, with ARUK being one of the fastest growing UK charities.